Kyverna Therapeutics, Inc. reports

Location
5980 Horton Street, Suite 550, Emeryville, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/12/2024, 04:20 PM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Aug 12, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 12, 2024 Aug 12, 2024
8-K Report | Data 8-K Jul 15, 2024 Jul 15, 2024
8-K Report | Data 8-K Jun 14, 2024 Jun 14, 2024
10-Q Report | Data 10-Q May 14, 2024 Mar 31, 2024
8-K Report | Data 8-K May 14, 2024 May 14, 2024
SC 13D Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP May 3, 2024
10-K Report 10-K Mar 26, 2024 Dec 31, 2023
8-K Report 8-K Mar 26, 2024 Mar 26, 2024
SC 13G Report SC 13G Feb 22, 2024
SC 13G Report SC 13G Feb 20, 2024
SC 13G Report SC 13G Feb 14, 2024
8-K Report 8-K Feb 12, 2024 Feb 12, 2024